[1] REED GW, ROSSI JE, CANNON CP. Acute myocardial infarction. Lancet. 2017;389(10065):197-210.
[2] THERY C, WITWER KW, AIKAWA E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.
[3] PEZZANA C, AGNELY F, BOCHOT A, et al. Extracellular Vesicles and Biomaterial Design: New Therapies for Cardiac Repair. Trends Mol Med. 2021;27(3):231-247.
[4] VAN NIEL G, D’ANGELO G, RAPOSO G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213-228.
[5] HOSHINO A, COSTA-SILVA B, SHEN TL, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329-335.
[6] YU X, DENG L, WANG D, et al. Mechanism of TNF-alpha autocrine effects in hypoxic cardiomyocytes: initiated by hypoxia inducible factor 1alpha, presented by exosomes. J Mol Cell Cardiol. 2012;53(6):848-857.
[7] WANG C, ZHANG C, LIU L, et al. Macrophage-Derived mir-155-Containing Exosomes Suppress Fibroblast Proliferation and Promote Fibroblast Inflammation during Cardiac Injury. Mol Ther. 2017;25(1): 192-204.
[8] MCGINLEY LM, MCMAHON J, STOCCA A, et al. Mesenchymal stem cell survival in the infarcted heart is enhanced by lentivirus vector-mediated heat shock protein 27 expression. Hum Gene Ther. 2013; 24(10):840-851.
[9] LAI RC, ARSLAN F, LEE MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010;4(3):214-222.
[10] TAN SJO, FLORIANO JF, NICASTRO L, et al. Novel Applications of Mesenchymal Stem Cell-derived Exosomes for Myocardial Infarction Therapeutics. Biomolecules. 2020;10(5):707.
[11] ARSLAN F, LAI RC, SMEETS MB, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 2013;10(3):301-312.
[12] WEN Z, MAI Z, ZHU X, et al. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway. Stem Cell Res Ther. 2020;11(1):36.
[13] PENG Y, ZHAO JL, PENG ZY, et al. Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2. Cell Death Dis. 2020;11(5):317.
[14] TENG X, CHEN L, CHEN W, et al. Mesenchymal Stem Cell-Derived Exosomes Improve the Microenvironment of Infarcted Myocardium Contributing to Angiogenesis and Anti-Inflammation. Cell Physiol Biochem. 2015;37(6):2415-2424.
[15] XU H, WANG Z, LIU L, et al. Exosomes derived from adipose tissue, bone marrow, and umbilical cord blood for cardioprotection after myocardial infarction. J Cell Biochem. 2020;121(3):2089-2102.
[16] FRANGOGIANNIS NG, SMITH CW, ENTMAN ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53(1):31-47.
[17] NAHRENDORF M, PITTET MJ, SWIRSKI FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 2010;121(22):2437-2445.
[18] ZHAO J, LI X, HU J, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res. 2019;115(7): 1205-1216.
[19] TALMAN V, RUSKOAHO H. Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res. 2016;365(3): 563-581.
[20] SÁNCHEZ-SÁNCHEZ R, GÓMEZ-FERRER M, REINAL I, et al. miR-4732-3p in Extracellular Vesicles From Mesenchymal Stromal Cells Is Cardioprotective During Myocardial Ischemia. Front Cell Dev Biol. 2021;9:734143.
[21] SUN L, ZHU W, ZHAO P, et al. Long noncoding RNA UCA1 from hypoxia-conditioned hMSC-derived exosomes: a novel molecular target for cardioprotection through miR-873-5p/XIAP axis. Cell Death Dis. 2020; 11(8):696.
[22] JUNG JH, IKEDA G, TADA Y, et al. miR-106a-363 cluster in extracellular vesicles promotes endogenous myocardial repair via Notch3 pathway in ischemic heart injury. Basic Res Cardiol. 2021;116(1):19.
[23] KHAN M, NICKOLOFF E, ABRAMOVA T, et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res. 2015;117(1):52-64.
[24] WU Q, WANG J, TAN WLW, et al. Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis. Cell Death Dis. 2020;11(5):354.
[25] KERVADEC A, BELLAMY V, EL HARANE N, et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J Heart Lung Transplant. 2016;35(6):795-807.
[26] YOSHIDA Y, YAMANAKA S. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications. Circ Res. 2017;120(12):1958-1968.
[27] ADAMIAK M, CHENG G, BOBIS-WOZOWICZ S, et al. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs. Circ Res. 2018;122(2):296-309.
[28] WANG Y, ZHANG L, LI Y, et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol. 2015;192:61-69.
[29] SAYED D, HE M, HONG C, et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem. 2010;285(26):20281-20290.
[30] KIM HW, HAIDER HK, JIANG S, et al. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem. 2009;284(48):33161-33168.
[31] GRUBER AJ, GRANDY WA, BALWIERZ PJ, et al. Embryonic stem cell-specific microRNAs contribute to pluripotency by inhibiting regulators of multiple differentiation pathways. Nucleic Acids Research. 2014; 42(14):9313-9326.
[32] MENDELL JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell. 2008;133(2):217-222.
[33] MÜLLER P, LEMCKE H, DAVID R. Stem Cell Therapy in Heart Diseases - Cell Types, Mechanisms and Improvement Strategies. Cell Physiol Biochem. 2018;48(6):2607-2655.
[34] YUE Y, WANG C, BENEDICT C, et al. Interleukin-10 Deficiency Alters Endothelial Progenitor Cell–Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment. Circ Res. 2020;126(3):315-329.
[35] WEN C, SEEGER RC, FABBRI M, et al. Biological roles and potential applications of immune cell-derived extracellular vesicles. J Extracell Vesicles. 2017;6(1):1400370.
[36] LONG R, GAO L, LI Y, et al. M2 macrophage-derived exosomes carry miR-1271-5p to alleviate cardiac injury in acute myocardial infarction through down-regulating SOX6. Mol Immunol. 2021;136:26-35.
[37] IKEDA G, SANTOSO MR, TADA Y, et al. Mitochondria-Rich Extracellular Vesicles From Autologous Stem Cell-Derived Cardiomyocytes Restore Energetics of Ischemic Myocardium. J Am Coll Cardiol. 2021;77(8): 1073-1088.
[38] GAO L, WANG L, WEI Y, et al. Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine. Sci Transl Med. 2020;12(561):eaay1318.
[39] GAO L, GREGORICH ZR, ZHU W, et al. Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine. Circulation. 2018;137(16):1712-1730.
[40] LIAO Z, CHEN Y, DUAN C, et al. Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction. Theranostics. 2021;11(1):268-291.
[41] DAVIDSON SM, DUCHEN MR. Endothelial mitochondria: contributing to vascular function and disease. Circ Res. 2007;100(8):1128-1141.
[42] SCARABELLI T, STEPHANOU A, RAYMENT N, et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation. 2001;104(3):253-256.
[43] SELA, MAGER I, BREAKEFIELD XO, et al. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013; 12(5):347-357.
[44] MURPHY DE, DE JONG OG, BROUWER M, et al. Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking. Exp Mol Med. 2019;51(3):1-12.
[45] YANG H, SUN W, QUAN N, et al. Cardioprotective actions of Notch1 against myocardial infarction via LKB1-dependent AMPK signaling pathway. Biochem Pharmacol. 2016;108:47-57.
[46] XUAN W, KHAN M, ASHRAF M. Extracellular Vesicles From Notch Activated Cardiac Mesenchymal Stem Cells Promote Myocyte Proliferation and Neovasculogenesis. Front Cell Dev Biol. 2020;8:11.
[47] MA J, ZHAO Y, SUN L, et al. Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D. Stem Cells Transl Med. 2017;6(1):51-59.
[48] GONG XH, LIU H, WANG SJ, et al. Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction. J Cell Physiol. 2019;234(8):13878-13893.
[49] NI J, LIU X, YIN Y, et al. Exosomes Derived from TIMP2-Modified Human Umbilical Cord Mesenchymal Stem Cells Enhance the Repair Effect in Rat Model with Myocardial Infarction Possibly by the Akt/Sfrp2 Pathway. Oxid Med Cell Longev. 2019;2019:1958941.
[50] MAO Q, LIANG XL, ZHANG CL, et al. LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis. Stem Cell Res Ther. 2019;10(1):393.
[51] LIU J, JIANG M, DENG S, et al. miR-93-5p-Containing Exosomes Treatment Attenuates Acute Myocardial Infarction-Induced Myocardial Damage. Mol Ther Nucleic Acids. 2018;11:103-115.
[52] WEI Z, QIAO S, ZHAO J, et al. miRNA-181a over-expression in mesenchymal stem cell-derived exosomes influenced inflammatory response after myocardial ischemia-reperfusion injury. Life Sci. 2019; 232:116632.
[53] PAN Z, SUN X, SHAN H, et al. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. Circulation. 2012;126(7):840-850.
[54] WANG J, LEE CJ, DECI MB, et al. MiR-101a loaded extracellular nanovesicles as bioactive carriers for cardiac repair. Nanomedicine. 2020;27:102201.
[55] SONG Y, ZHANG C, ZHANG J, et al. Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction. Theranostics. 2019;9(8):2346-2360.
[56] LI Q, XU Y, LV K, et al. Small extracellular vesicles containing miR-486-5p promote angiogenesis after myocardial infarction in mice and nonhuman primates. Sci Transl Med. 2021;13(584):eabb0202.
[57] DE ABREU RC, FERNANDES H, DA COSTA MARTINS PA, et al. Native and bioengineered extracellular vesicles for cardiovascular therapeutics. Nat Rev Cardiol. 2020;17(11):685-697.
[58] ZHANG N, SONG Y, HUANG Z, et al. Monocyte mimics improve mesenchymal stem cell-derived extracellular vesicle homing in a mouse MI/RI model. Biomaterials. 2020;255:120168.
[59] WANG X, CHEN Y, ZHAO Z, et al. Engineered Exosomes With Ischemic Myocardium-Targeting Peptide for Targeted Therapy in Myocardial Infarction. J Am Heart Assoc. 2018;7(15):e008737.
[60] LAI CP, MARDINI O, ERICSSON M, et al. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano. 2014;8(1):483-494.
[61] LIU B, LEE BW, NAKANISHI K, et al. Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells. Nat Biomed Eng. 2018; 2(5):293-303.
[62] WEI Z, CHEN Z, ZHAO Y, et al. Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment. Biomaterials. 2021;275:121000.
[63] ZHU LP, TIAN T, WANG JY, et al. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction. Theranostics. 2018; 8(22):6163-6177.
[64] TIAN T, ZHANG HX, HE CP, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137-149.
[65] NAKASE I, NOGUCHI K, FUJII I, et al. Vectorization of biomacromolecules into cells using extracellular vesicles with enhanced internalization induced by macropinocytosis. Sci Rep. 2016;6:34937.
[66] NAKASE I, NOGUCHI K, AOKI A, et al. Arginine-rich cell-penetrating peptide-modified extracellular vesicles for active macropinocytosis induction and efficient intracellular delivery. Sci Rep. 2017;7(1):1991.
[67] LIU C, BAYADO N, HE D, et al. Therapeutic Applications of Extracellular Vesicles for Myocardial Repair. Front Cardiovasc Med. 2021;8:758050.
[68] WATERS R, ALAM P, PACELLI S, et al. Stem cell-inspired secretome-rich injectable hydrogel to repair injured cardiac tissue. Acta Biomater. 2018;69:95-106.
[69] LV K, LI Q, ZHANG L, et al. Incorporation of small extracellular vesicles in sodium alginate hydrogel as a novel therapeutic strategy for myocardial infarction. Theranostics. 2019;9(24):7403-7416.
[70] HAN C, ZHOU J, LIANG C, et al. Human umbilical cord mesenchymal stem cell derived exosomes encapsulated in functional peptide hydrogels promote cardiac repair. Biomater Sci. 2019;7(7):2920-2933.
|